Skip to content
  • Topics
    • Obesity/Cancer FAQs
    • General News
    • Gastroparesis
    • Learn about Lipids
      • Obese vs Non-Obese
    • Obesity Drugs
      • Semaglutide
      • Tirzepatide
      • Obesity Drugs in the Pipeline
    • Lawsuits
    • Bariatric Surgery
    • Grants
    • Addiction
    • Journals/References/Books
    • Clinical Trials
      • Clinical Trials – United States
      • Clincal Trials – ExUS
      • Breast Cancer-Obesity Clinical Trials
    • FDA
    • Conferences
      • Conference Updates
    • Institutions
  • Blog Posts / News
    • Login
    • News Archive
    • Posts Archive
    • Guest Post
    • Author’s Registration Page
    • Author’s Post Page
    • Bloggers
  • Related Cancers
    • Breast
    • Colon & Rectum
    • Kidney
    • Endometrium
    • Pancreas
    • Thyroid
    • Liver
    • Multiple Myeloma
    • Upper Stomach
    • Meningioma
    • Adenocarcinoma of the Esophagus
    • Ovary
    • Gallbladder
    • Pediatric
    • Mesothelioma
  • About
  • Contact
  • Topics
    • Obesity/Cancer FAQs
    • General News
    • Gastroparesis
    • Learn about Lipids
      • Obese vs Non-Obese
    • Obesity Drugs
      • Semaglutide
      • Tirzepatide
      • Obesity Drugs in the Pipeline
    • Lawsuits
    • Bariatric Surgery
    • Grants
    • Addiction
    • Journals/References/Books
    • Clinical Trials
      • Clinical Trials – United States
      • Clincal Trials – ExUS
      • Breast Cancer-Obesity Clinical Trials
    • FDA
    • Conferences
      • Conference Updates
    • Institutions
  • Blog Posts / News
    • Login
    • News Archive
    • Posts Archive
    • Guest Post
    • Author’s Registration Page
    • Author’s Post Page
    • Bloggers
  • Related Cancers
    • Breast
    • Colon & Rectum
    • Kidney
    • Endometrium
    • Pancreas
    • Thyroid
    • Liver
    • Multiple Myeloma
    • Upper Stomach
    • Meningioma
    • Adenocarcinoma of the Esophagus
    • Ovary
    • Gallbladder
    • Pediatric
    • Mesothelioma
  • About
  • Contact

AbbVie Joins Obesity Treatment Market With Up to $2.2B Licensing Deal – Investopedia

Monday, March 3, 2025 – ... Zepbound, which involve the hormone GLP-1. Shares of AbbVie gained more ... Zepbound injection ...

  • Condie Carmack
  • March 3, 2025
  • Uncategorized

Biotech’s top money raisers: 2024

Monday, March 3, 2025 – ... GLP-1 drugs—including an injectable GLP-1/GIP receptor dual agonist and an oral small-molecule GLP-1 receptor agonist, both clinical-stage ...

  • Condie Carmack
  • March 3, 2025
  • Uncategorized

GLP-1 Drugs Offer More Than Weight Loss and Glucose Control – Medscape

Monday, March 3, 2025 – Dr Priya Jaisinghani discusses the benefits of GLP-1 therapy beyond glycemic control and weight management.

  • Condie Carmack
  • March 3, 2025
  • Uncategorized

Conagra ‘GLP-1 Friendly’ Badge Taps the Weight Loss Drug Craze – Packaging Digest

Monday, March 3, 2025 – Select Healthy Choice frozen meal packages get a makeover with an "On Target" nutritional badge to target the 15.5 million US adults taking GLP-1 ...

  • Condie Carmack
  • March 3, 2025

Opinion: Are discount diet drugs safe? No one knows | The River Reporter

Monday, March 3, 2025 – ... compounded GLP-1 weight-loss drugs that are cheaper than the authentic prescription versions like Zepbound and Ozempic. These ads …

  • Condie Carmack
  • March 3, 2025
  • Uncategorized

Emergency Medicine Faculty Member Helping NASA to Solve the Problems of Medical Care …

Monday, March 3, 2025 – ... CU Researcher Studying Effects of GLP-1 Drugs on Alcohol Addiction. by Greg Glasgow | Feb 7, 2025 ...

  • Condie Carmack
  • March 3, 2025
  • Uncategorized

GLP-1 Receptor Agonist Use Not Linked to Increased Suicide Risk – Drugs.com MedNews

Monday, March 3, 2025 – Glucagon-like peptide-1 (GLP-1) receptor agonists are not associated with an increased risk for suicidality compared with dipeptidyl peptidase-4 ...

  • Condie Carmack
  • March 3, 2025
  • Uncategorized

Trouble sleeping? The culprit may be something you ate – American Heart Association

Monday, March 3, 2025 – Among women, it altered levels of GLP-1, reducing satiety, meaning women felt less full after eating. So what foods should people eat if they want ...

  • Condie Carmack
  • March 3, 2025
  • Uncategorized

Hims & Hers Stock Dip and What It Means for Telehealth and Clinicians

Monday, March 3, 2025 – ... semaglutide shortage had been resolved. Semaglutide is the active ingredient in weight loss meds like Ozempic and Wegovy, and compounding is legal ...

  • Condie Carmack
  • March 3, 2025

AbbVie gets into obesity with $350M deal for once-weekly shot | BioPharma Dive

Monday, March 3, 2025 – If successful, these drugs could be used as alternatives to or in combination with marketed drugs like Novo's Wegovy and Lilly's Zepbound to increase ...

  • Condie Carmack
  • March 3, 2025
Prev
1 … 17 18 19 20 21 22 23 … 25
Next
© Copyright 2026 GenWeb of Texas

Insert/edit link

Enter the destination URL

Or link to existing content

    No search term specified. Showing recent items. Search or use up and down arrow keys to select an item.